Inventor · disambiguated record
Wyndham Wilson
Also filed as: WILSON WYNDHAM · WILSON WYNDHAM H · WILSON WYNDHAM HOPKINS
9 granted patents·10 pending applications·78 citations·filing 1994–2023
85Inventor score
Top patents by PatentIndex Score
19 records- 0186US7329502B2ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)US HEALTH·Filed 2002·Granted Feb 12, 2008·22 cites·14 claims
- 0283US8131475B2Methods for identifying, diagnosing, and predicting survival of lymphomasSTAUDT LOUIS M·Filed 2006·Granted Mar 6, 2012·10 cites·6 claims
- 0383US2024065971A1Methods of treating abc-dlbcl using inhibitors of brutons tyrosine kinasePHARMACYCLICS LLC·Filed 2023·Application pending·0 cites
- 0480US7981610B2ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)US HEALTH·Filed 2007·Granted Jul 19, 2011·2 cites·10 claims
- 0572US5496846ATaxol treatment of breast cancerUS ARMY·Filed 1994·Granted Mar 5, 1996·44 cites·1 claims
- 0669US2020246259A1Methods of treating abc-dlbcl using inhibitors of brutons tyrosine kinasePHARMACYCLICS LLC·Filed 2020·Application pending·0 cites
- 0768US2018311153A1Methods of treating abc-dlbcl using inhibitors of bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2017·Application pending·0 cites
- 0863US11028444B2Survival predictor for diffuse large B cell lymphomaUS HEALTH·Filed 2018·Granted Jun 8, 2021·0 cites·4 claims
- 0963US2016243033A1Methods of treating abc-dlbcl using inhibitors of bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2015·Application pending·0 cites
- 1062US2012071497A1Methods of treating abc-dlbcl using inhibitors of bruton's tyrosine kinaseBUGGY JOSEPH J·Filed 2011·Application pending·0 cites
- 1160US2012225793A1Methods for identifying, diagnosing, and predicting survival of lymphomasSTAUDT LOUIS M·Filed 2012·Application pending·0 cites
- 1260US2023010803A1Treatments for diffuse large b-cell lymphomaJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1359US8748114B2ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)STAUDT LOUIS M·Filed 2011·Granted Jun 10, 2014·0 cites·20 claims
- 1458US2011195064A1Survival predictor for diffuse large b cell lymphomaUS HEALTH·Filed 2009·Application pending·0 cites
- 1557US10697975B2Methods for identifying, diagnosing, and predicting survival of lymphomasUS HEALTH·Filed 2017·Granted Jun 30, 2020·0 cites·5 claims
- 1657US9970059B2Survival predictor for diffuse large B cell lymphomaUS HEALTH·Filed 2014·Granted May 15, 2018·0 cites·16 claims
- 1744US2005244828A1Elisa assay of serum soluble cd22 to assess tumor burnden/relapse in subjects with leukemia and lymphomaKREITMAN ROBERT J·Filed 2003·Application pending·0 cites
- 1841US2014363456A1Tumor-specific gm-csf cytokine response as predictor of cancer vaccine effectivenessBIOVEST INT INC·Filed 2012·Application pending·0 cites
- 1925USRE40839ETaxol treatment of cancerUS HEALTH·Filed 1998·Granted Jul 7, 2009·0 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →